studyId: syn53604892 studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment accessType: Private initiative: Other fundingAgency: Other
Drop files to upload
treatment-vs-dmso-directional-de-pathway-analysis.html page is loading…